Skip to main
LYRA
LYRA logo

Lyra Therapeutics (LYRA) Market Capitalization Overview

Market Cap: $15.03M as of Jun 13, 2025

$15.03M
Past Month+$7.68M (104.23%)
As of Jun 13, 2025, Lyra Therapeutics (LYRA) has a market capitalization of $15.03M. Over the past 30 days, its market cap has increased by 265.36%, while in the last 12 months, it has increased by 11.14%.

Market capitalization represents the total value of Lyra Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Lyra Therapeutics (LYRA) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Lyra Therapeutics (LYRA) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Lyra Therapeutics (LYRA) Market Cap History

DateMarket CapChange
Jun 2, 2025$26.84M+265.36%
May 1, 2025$7.35M-7.16%
Apr 1, 2025$7.92M-37.88%
Mar 3, 2025$12.74M+6.64%
Feb 3, 2025$11.95M-15.60%
Jan 2, 2025$14.16M+0.65%

Lyra Therapeutics (LYRA) End of Year Market Cap History

DateMarket CapChange
2025$15.03M+11.14%
2024$13.53M-94.79%
2023$259.62M+159.78%
2022$99.94M+76.22%
2021$56.72M-61.53%
2020$147.43M

FAQs About Lyra Therapeutics (LYRA) Market Cap

As of Jun 13, 2025, the market capitalization of Lyra Therapeutics (LYRA) is $15.03M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Lyra Therapeutics’s market capitalization has increased by 104.23%, changing from $7.36M to $15.03M as of Jun 13, 2025.

In the last 3 months, Lyra Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Lyra Therapeutics’s market capitalization decreased from $259.62M in January to $13.53M in December, reflecting a -94.79% change.

In the past five years, Lyra Therapeutics (LYRA) has had a compound annual growth rate (CAGR) of -37.99% in market capitalization. This means its market cap has shrunk at an average rate of -37.99% per year.

Lyra Therapeutics (LYRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.